The latest headlines across every section, pulled from official and open-access sources.
This randomized clinical trial assesses whether instruction delivery of the Patient Health Questionnaire-9 (PHQ-9) and the General Anxiety Disorder-7 (GAD-7) may influence symptom scores among US adults with anxiety or depression.
This cross-sectional study examines associations of sexual orientation with burnout among emergency medicine residents.
This cross-sectional study evaluates the association of state Supplemental Nutrition Assistance Program–related policies with county-level cardiovascular mortality rates.
This study from the INSPIRE-T Lifespan Translational Cohort evaluates whether accelerated epigenetic and inflammatory aging is associated with global intrinsic capacity, a multidomain measure of physical and mental health.
This cross-sectional study evaluates prevalence estimates, factors associated with, and treatment utilization among US military veterans with a history of suicidal thoughts and behaviors.
This cohort study examines whether spouses of individuals with dementia have an increased risk of developing dementia.
The FIFA World Cup 2026(TM) brought 48 teams and millions of fans to 16 North American cities.
Relay Peak Research LLC (Zen Principle Naturals) of Incline Village, NV is voluntarily recalling its Zen Principle® brand Moringa Capsules dietary supplement because the product has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections i
Merck’s Lipfendra is the first FDA-approved pill in the class of cholesterol-lowering drugs called PCSK9 inhibitors. While peptides are typically injected, Lipfendra is a macrocyclic peptide designed for formulation as an oral drug. The post Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs appeared first on MedCity News .
Latigo Biotherapeutics is preparing to go public in order to bankroll the development of its clinical-stage pipeline of non-opioid pain management drugs.
What should life sciences investors and targets focus on for dealmaking success? Here are six actionable steps. The post Hybrid Financing in Life Sciences: Unlocking Growth Amid Market Challenges appeared first on MedCity News .
Here’s what healthcare entities should know about the maturing landscape, what to actually be concerned about, and the next stage of healthcare data evolution as we know it. The post Are We Entering an Interoperability Trust Recession? appeared first on MedCity News .
Original new drug approval. gas, inhalation. Sponsor: Noble Gas Solutions Inc.
Geopolitical uncertainty has continued to “chill” IPO sentiment among British biotechs, an industry leader has told Fierce, even as the sector saw second-quarter venture capital funding reach a five-year high.
The FIFA World Cup 2026(TM) brought 48 teams and millions of fans to 16 North American cities.
Abbott has been struck by several cyberattacks which targeted the medtech giant’s cancer diagnostics and LabCentral businesses.
After Eli Lilly dived into the psychedelics space with a $2.8 billion upfront acquisition of AtaiBeckley last week, industry experts told Fierce that the deal would give the space added momentum.
KFF Health News journalists made the rounds on national or local media recently to discuss topical stories. Here’s a collection of their appearances.
WHO Member States have advanced negotiations on the Pathogen Access and Benefit Sharing (PABS) annex, a central component of the WHO Pandemic Agreement, while agreeing that continued discussions are needed to finalize a framework that supports a faster, more effective and equitable response to future pandemics.
Fayus Inc., doing business as Yusol International Foods (Sacramento, CA) is expanding its recall of OLA-OLA POUNDED YAM to include product sizes 2lbs, 4lbs, 5lbs, and 10lbs due to product labeling omission of an undeclared milk allergen for sodium caseinate, a milk derivative. People who have an all
Juno Bio’s funding was supported by Ada Ventures, Artesian, Entrepreneur First and Illumina Accelerator. The post Juno Bio Raises $3.8M to Support Vaginal Health appeared first on MedCity News .
HSS chief digital and information officer Ashis Barad, who has worked on both the payer and provider sides of healthcare AI, thinks the industry’s growing “bot vs. bot” battle over prior authorizations and appeals is driving costs up. To him, the real fix lies in providers and payers sharing data to build more personalized care pathways. The post The ‘Bot Vs. Bot’ Dynamic Between Providers & Payers Is Driving Up Costs for Everyone appeared first on MedCity News .
GSK said the mixed Phase 3 results for camlipixant mean this pill “is unlikely to transform patient care” in recurrent chronic cough. GSK is stopping work in this indication, a setback to a program once hoped to yield a new blockbuster product for the company’s respiratory drug portfolio. The post GSK Drug From $2B Deal Sputters in Phase 3 Test in Chronic Cough appeared first on MedCity News .
Venture capital funding deals worth $100 million or more made up nearly half of all money invested so far this year, according to Rock Health.